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Abstract

IMPACT OF ISCHEMIC TIME ON FUNCTIONAL EXERCISE CAPACITY AFTER
ORTHOTOPIC HEART TRANSPLANTATION
Katelyn Brown
Thesis Chair: Arturo A. Arce-Esquivel M.D., Ph.D.
The University of Texas at Tyler
November 2019
Purpose: Ischemic time (IT) is an independent risk factor for poor functional
exercise capacity (FEC) following orthotopic heart transplantation (OHT). The OHT
recipient’s post-transplant FEC (peak VO2) is directly associated with improved quality
of life. However, there is debate in the literature about the deleterious impact of extended
IT on FEC following OHT.
Methods: Fifteen OHT recipients (14 men and 1 woman; < 3 months from OHT)
performed a symptom-limited graded CPET where peak VO2 was measured in an
outpatient cardiac rehabilitation. IT was obtained from the anesthesia post-operative note.
VO2 and IT values were dichotomized based on previous literature; high, ≥14 mL/kg/min
(or ≥12 mL/kg/min if taking a beta blocker), and low, <14 mL/kg/min (or <12
mL/kg/min if taking a beta blocker), and short, <180 min and long, ≥180 min,
respectively. A Fisher’s Exact Test was used to determine if extended IT is associated
with decreased FEC.
Results: The median (IQR) recipient and donor characteristics are presented in
Table 3. The Fisher’s Exact Test yielded a p value of 0.62.
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Conclusions: Extended IT was not associated with decreased FEC in the months
following OHT in those recipients who survived to discharge with stamina sufficient to
engage in outpatient cardiac rehabilitation. The wider IQR of peak VO 2 in recipients with
extended IT, despite the higher number of recipients, suggests that while properly
selected allografts are able to tolerate a longer IT without compromising intermediate
term FEC, this is not a homogenous correlation and other peri-transplant factors may
modify FEC.
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Chapter 1
Introduction and Background
Orthotopic Heart Transplantation (OHT)
As the battle against the nation’s leading cause of death, heart disease, continues
to expand, orthotopic heart transplantation (OHT) remains a feasible option for the
treatment of end-stage heart failure (HF). OHT is the current gold standard for the
treatment of HF due to its potential to extend the life of the recipient, improve the
recipient’s quality of life (QOL), and functional capacity. 1 Furthermore, OHT has been
more effective in decreasing mortality and improving QOL in comparison to alternative
HF treatments such as Left Ventricular Assist Device (LVAD) or medical management. 2
More than 70,000 OHTs have been performed since 19883 and, due to advancements in
technology, the number per year is steadily increasing. 4

Transplant Donor Guidelines and Organ Procurement

As more patients require OHT, the demand for suitable donor hearts is likely to
increase and currently outweighs the supply of available donor organs. In order to
accommodate the need for eligible donor hearts, many institutions are working to expand
the criteria for what constitutes an acceptable donor heart. Since OHT outcomes are
complex and multifaceted, multiple donor qualities and organ procurement and
preservation techniques have been reexamined in the hopes of improving the accessibility
of OHT. Donor characteristics, such as age and previous health status, have been a
growing topic of interest for years, ultimately allowing for an expansion in the donor
1

pool. For example, in the late 1980’s, donor hearts were only deemed transplantable if the
donor was younger than 35 years of age for men and 40 years of age for women. 5
Recently, however, research has explored the implications of transplanting older donor
hearts and older recipients but no age limit has been established.6, 7

In addition to donor specific qualities, investigation into donor heart preservation
and procurement guidelines has allowed for potential change in the previous donor organ
requirements. For example, OHT clinicians have suggested that by increasing the time
allowable for a donor heart to reach its destination, donor hearts may become accessible
to people in more remote locations (or the most ill nationwide/worldwide). However,
more distant destinations may require the donor heart to remain under-perfused for longer
periods of time. This characteristic of donor heart preservation, called ischemic time (IT),
is currently under investigation. Longer IT may allow for increased availability of donor
hearts, but the implications of extended IT are not fully understood.

Heart Ischemic Time (IT)
Heart IT is defined as “the time that an organ is outside the body when the heart
is not beating and/or supplied with oxygen by the coronary arteries.”8 According to
traditional research and guidelines, is ideal when IT is less than 240 minutes. 5,7 However,
some institutions remain more conservative with idealistic IT of 180 minutes or less.9
While some studies have found that IT is an independent risk factor for mortality and
poor prognosis following OHT,10,11 other studies suggest that extended IT has no impact
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on long term survival.12 Moreover, several case studies have investigated donor IT of up
to six hours (360 minutes) with no difference in mortality up to 36 months posttransplant.13 In regards to post-surgical complications and resource allocation, one study
suggested that there is no difference in the risk for primary graft dysfunction, length of
hospital stay, need for inotropic or ventilatory support or rejection associated with donor
IT of less than 4 hours and 4 to 5 hours, but the risk begins to increase after 5 hours. 10
Although there are interventions being explored to minimize the ischemic damage of
donor hearts with prolonged IT14, there is still ongoing discussion as to what constitutes a
suitable IT for OHT.

Ischemic Time and Functional Exercise Capacity (FEC)

As there is ongoing debate in the literature regarding long-term impact of
prolonged IT on patients with OHT, it is imperative to understand the impact IT has on
the donor heart’s capacity to do work after OHT. It has been suggested that patients
experience a decreased exercise capacity following OHT when compared to healthy
individuals,14,15 which impacts the overall functional exercise capacity (FEC) of the OHT
recipient. FEC is a significant component in an individual’s ability to perform activities
of daily living, participate in recreational and occupational ventures and is associated
with QOL after OHT. 2 Low QOL has been associated with increased symptoms of
depression and anxiety in OHT recipients 16, which makes it imperative for healthcare
professionals to understand the impact prolonged IT may have on the recipient’s
prognosis.
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Given that increased IT may impact cardiac functioning following adult OHT, the
impact of IT on FEC should warrants further investigation in order to further understand
the implications of using donor hearts with extended IT. In one landmark study, shorter
IT was related to increased FEC in OHT recipients two months post-transplant, but this
study was not sensitive to the variable needs of the OHT patient population. 16 This
particular study estimated the patients’ FEC merely by the number of metabolic
equivalents (METs) they were able to achieve, without the use of metabolic-cart gas
analysis, on a Bruce treadmill protocol. Although, this study provides valuable
information; it is not inclusive of the many OHT recipients that may be unable to perform
this test due to orthopedic limitations, severe deconditioning observed with end-stage
heart failure, and the large increase in speed and incline with each progressive stage.
Therefore, in order to create a more inclusive and specific investigation into the
impact of prolonged IT on FEC, a symptom-limited, cardiopulmonary exercise test
(CPET) should be used involving a modality and protocol best suited for the individual
patient.

Purpose
The purpose of this study was to investigate the effect that donor IT has on FEC,
measured by peak volume of oxygen consumption (VO2), in adults after OHT.

4

Chapter 2
Methods

Study Design

A prospective, observational study was performed on 15 OHT recipients between
January 2019 and October 2019 who were enrolled at the Walter I. Berman
Cardiovascular Rehabilitation (CR) and Prevention Center at Baylor Scott and White
Heart and Vascular Hospital in Dallas, Texas. All subjects enrolled were
hemodynamically stable adult outpatients who underwent OHT fewer than 90 days
before enrollment in the study.
Inclusion and Exclusion Criteria Table 1 provides the inclusionary and
exclusionary criteria for the study.

Table 1. Inclusion and Exclusion Criteria for Patient Enrollment
Inclusion Criteria

Exclusion Criteria

Male or female

Orthopedic, neurologic or other limitations that
prevent exercise testing on a treadmill or cycle
ergometer

Hemodynamically stable
Outpatient enrolled in cardiac rehabilitation

Requiring supplemental oxygen

Recipient of OHT within three months from
enrollment date

Current permanent tracheostomies

18 to 80 years of age
Able to read and understand an informed consent

Patients discharged to a long-term acute care
facility; skilled nursing facility or with
palliative/hospice care
Inmates
Pregnant women

5

Subject Identification

Potential subjects were identified upon admission to the CR program by use of a
screening tool illustrating inclusion and exclusion criteria. Patients who met the inclusion
criteria were offered participation in the study and if agreeable, were taken through the
informed consent process during their first day of CR.

Cardiopulmonary Exercise Testing (CPET)

An order requesting a CPET was signed and dated by the subject’s cardiothoracic
transplant surgeon, cardiologist, appropriately licensed advanced practice healthcare
provider with heart transplant expertise, or primary care physician. Upon admission to the
CR program, subjects were scheduled to perform a CPET on either an upright cycle
ergometer or treadmill depending on level of comfort and fall risk assessment performed
by a registered nurse on the day of testing. Subjects were fitted for metabolic testing
(Quark CPET, COSMED, Concord, CA or similar) equipment according to factory
requirements and a lead II ECG monitor was attached to the subject (ScottCare
VersaCare Telemetry Monitoring System, Cleveland, Ohio or similar) to monitor for
arrythmias. Each subject was asked to perform the CPET to the best of their abilities. The
modified Borg Rating of Perceived Exertion (RPE-CR10) scale was used during the
testing.17 The RPE-CR10 (1 to 10) scale is a common method for determining exercise
intensity levels, where “0” = nothing at all and “10” = very, very hard. The traditional
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Borg scale (6-20) was not used due to the disassociation between level of difficulty and
heart rate seen in a denervated heart. Continuous blood pressure (BP) measurements were
taken to ensure hemodynamic stability and lead II ECG was monitored continuously by
telemetry staff.

Termination Criteria

The CPET was terminated if any of the following occurred: (a) subject became
symptomatic; (b) increased pain reported; (c) subject asked to terminate test; (d)
dangerous arrhythmias reported on ECG; (e) unsafe drop in BP or over 250/120 mmHg
reported; or (f) subject reported a “10” on RPE-CR10 scale, indicating maximal effort.
Other termination of the test was reserved for the clinical judgment of research staff to
ensure safety of the subject. After termination of the test, subject was instructed to
perform a cool-down of 3 to 5 minutes. The CPET was performed in an area with
immediate access to a “crash cart”, a supervising physician, and clinical staff trained in
advanced cardiac life support. Donor organ-specific data was gathered through the UNOS
Donor Infection ID and Match Run and matched with the corresponding printed CPET
report after completion of the test.

Statistical Analysis
The main exposure of this study was duration of IT. The overall median inter
quartile range (IQR) of IT were calculated according to standard methods. IT was further
dichotomized into longer and shorter IT using cutoff of 180 minutes. 9,18 The main
7

outcome of this study was the subject’s FEC, measured by peak VO2, which was
dichotomized into lower and higher FEC using a pre-specified cutoff of 14 mL/kg/min
and a pre-specified supplemental analysis was performed using a dichotomous cutoff of
12 mL/kg/min. These two cut-offs were selected as they represent the standard thresholds
below which transplant is most typically justified in an ambulatory, non-inodilatordependent subject (14 mL/kg/min for pre-transplant patients without current beta blocker
use and 12 mL/kg/min with beta blocker use). 9,17 Data are shown as percentages or n for
categorical variables and compared between subjects with lower FEC and those with
higher FEC using a Fisher’s Exact Test; medians IQR for continuous variables were
calculated according to standard methods. Data were analyzed using NCSS 11 (NCSS,
LLC - Kaysville, UT).
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Chapter 3
Results
Patient Characteristics
The patient demographics and characteristics information for this cohort can be
depicted in Table 2 below.

Table 2. Patient Characteristics Demographics
Characteristics/Demographics

Median (IQR) or %

Age (years)

58 (10.7)

Height (cm)

175.26 (7.37)

Body weight (kg)

83.46 (16.92)

Resting HR (bpm)

112 (10)

Asian

6.67%

Black

20.00%

Hawaiian

6.67%

White
Hispanic

66.67%
6.67%

Fall Risk

46.6%

Modified “Slow” USAFSAM

53.33%

Beta Blocker Use

6.67%
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Comparison of IT and FEC

The comparison between the long IT and short IT groups as well as the High FEC
and Low FEC groups is detailed in Table 3 and visualized in Figure 1. The results of the
Fisher’s Exact Tests yielded a p value of 0.62.

Table 3. Median (IQR) Donor and Recipient Characteristics Comparing IT and FEC
Long IT

Short IT

Total

Donor age (years)

45 (31)

38 (13)

42 (26)

Recipient age (years)

60 (14)

65 (12)

60 (10)

IT (minutes)

249 (46)

115 (52)

224 (148)

VO2 (mL/kg/min)

14.4 (7.0)

14.0 (3.6)

14.4 (4)

High FEC

n= 6

n= 3

15.8 (3.3)

Low FEC

n= 3

n= 3

11.3 (2.7)
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Figure 1. Box Plot of Median Peak VO2 in Long and Short Ischemic Time Categories
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Chapter 4
Conclusions and Implications
Interpretation of Results

According to the analysis performed in this cohort, extended IT (>180 minutes)
was not associated with decreased FEC (<14 mL/kg/min or <12 mL/kg/min with beta
blocker use) in the months following OHT in recipients who survived to discharge with
stamina sufficient to engage in an outpatient CR program. The wider IQR of peak VO 2 in
OHT recipients with extended IT, despite the higher number of recipients, suggests that
while properly selected allografts can tolerate a longer IT without compromising
intermediate term FEC, this is not a homogenous correlation and other peri-transplant
factors may modify FEC.

Comparison of Results to the Literature
These results do not support the findings of Buendia-Fuentes et. al., regarding
donor and recipient specific qualities that impact functional recovery in the 2 months
following transplant.16 This discrepancy may be in part due to the method used to test and
evaluate OHT recipients. Those investigators, used the Bruce treadmill protocol, which
utilizes steep incline and speed increases each progressing stage. Functional capacity was
also estimated using METs, which are not representative of this population due to an
abnormal response to exercise.15,18 Since breath-by-breath gas analysis and a more
individualized testing modality were used in the present study, this may more accurately
12

reflect their actual peak VO 2. For subjects that did not present as a fall risk, a modified
USAFSAM treadmill protocol (for CHF patients) was used and for those who were
deemed unsafe to perform a CPET on a treadmill, a 10 W ramp cycle ergometer protocol
was used.19 Future studies, might need to analyze differences that may exist between
cycle ergometry and treadmill outcomes in this clinic population, as we know that VO2
may be underestimated in cycle ergometry testing.20
Limitations
Although the results of the present study provide valuable insight into the
relationship between donor IT and the ability of the transplanted heart to do work in the 3
months immediately following surgery, it is not without limitations, particularly due to
the small size. Due to the United Network for Organ Sharing’s revision to the adult heart
allocation policy in October 2018, an increased percentage of OHT recipients required
placement post-discharge from the acute-care setting and consequently were ineligible to
participate in the study.21 The increasing accessibility of extracorporeal membrane
oxygenation and temporary mechanical circulatory support devices (Impella, intra-aortic
balloon pump, etc.), allowing the most critical patients to survive until transplant, resulted
in additional orthopedic and neurologic limitations that restricted exercise testing.
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Future Recommendations
The investigation into the effect extended IT has on FEC after OHT could be
strengthened by a larger sample, across multiple transplant centers, with a longitudinal
analysis to account for effect of IT on long-term functional allograft recovery. Due to the
variation in results in the literature surrounding the possible impact of increasing IT on
the immediate and long-term allograft function post OHT, in addition to the association
between FEC and QOL, further investigation is warranted exploring the impact of longer
IT.
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